Biogen Inc. (NASDAQ:BIIB)

An analysis of the economic value creation between 2017 and 2021 reveals a period of significant growth followed by a sharp contraction in profitability. The organization experienced a peak in value generation in 2019, after which a precipitous decline in operating performance occurred, significantly eroding the economic profit by the end of the period.

Net Operating Profit After Taxes (NOPAT)

A strong upward trajectory was observed from 2017 to 2019, with NOPAT increasing from 2,890,089 thousand US$ to a peak of 6,023,385 thousand US$. This growth phase was followed by a severe downturn; NOPAT decreased to 4,370,868 thousand US$ in 2020 and plummeted to 1,501,467 thousand US$ by December 31, 2021, representing a substantial reduction in core operational profitability.

Invested Capital and Cost of Capital

Invested capital grew steadily from 12,476,129 thousand US$ in 2017 to a peak of 14,142,400 thousand US$ in 2019. A temporary contraction occurred in 2020, followed by an increase to 13,824,500 thousand US$ in 2021. Concurrently, the cost of capital remained relatively stable, oscillating near 9.5% before trending downward to 8.64% by 2021. The decrease in the cost of capital was insufficient to offset the decline in operating profits.

Economic Profit

Economic profit mirrored the trend of NOPAT, expanding from 1,705,874 thousand US$ in 2017 to a maximum of 4,694,062 thousand US$ in 2019. However, a sharp reversal is evident in the final two years of the period. By 2021, economic profit fell to 307,383 thousand US$, indicating that the company barely exceeded its cost of capital, marking a near-complete erosion of the economic value added during the peak years.

The overall trend indicates that while the company successfully expanded its economic footprint and value creation through 2019, the subsequent collapse in NOPAT led to a critical decline in economic profit, despite a marginally lower cost of capital and relatively stable invested capital levels.

Net Income Attributable to Biogen Inc.

The net income exhibited a rising trend from 2017 to 2019, increasing from approximately 2.54 billion to nearly 5.89 billion US dollars. However, a decline was observed starting in 2020, with net income falling to about 4.00 billion and further decreasing sharply to approximately 1.56 billion US dollars in 2021. This indicates a significant reduction in profitability during the latter years of the period.

Net Operating Profit After Taxes (NOPAT)

The NOPAT followed a similar trajectory to net income, showing an increase from about 2.89 billion US dollars in 2017 to a peak of approximately 6.02 billion US dollars in 2019. Subsequently, a decline occurred with NOPAT decreasing to roughly 4.37 billion in 2020 and then sharply dropping to around 1.50 billion US dollars in 2021. This pattern signifies a reduction in operating efficiency and effectiveness in generating profit after taxes over the last two years.

Overall Observations

Both net income and NOPAT demonstrated growth during the initial three years, suggesting improved financial performance and operational results. The peak in 2019 represents the highest point in profitability within the analyzed period. The subsequent decline in 2020 and more pronounced drop in 2021 highlight challenges or adverse developments affecting profitability and operational outcomes. The data suggests the company experienced a notable downturn in earning capacity and operating profit in the final years.

Income Tax Expense

The income tax expense demonstrates a consistent downward trend from 2017 to 2021. Starting at 2,458,700 thousand US dollars in 2017, the expense decreased significantly each year to reach 52,500 thousand US dollars in 2021. The reduction is particularly notable in 2021, where the expense dropped sharply compared to previous years.

Cash Operating Taxes

Cash operating taxes also show a general decline over the analyzed period. Beginning at 2,441,355 thousand US dollars in 2017, these taxes declined steadily year over year, falling to 533,599 thousand US dollars in 2021. The reduction is gradual until 2020, followed by a less steep but still notable decrease in 2021.

Comparative Analysis

Both income tax expense and cash operating taxes have followed a downward trajectory, reflecting a possible strategic or operational improvement affecting taxable income or tax planning. The income tax expense decreased more sharply between 2020 and 2021 compared to prior years, whereas cash operating taxes reduced more steadily across the entire timeframe.

Total Reported Debt & Leases

The total reported debt and leases remained relatively stable from 2017 to 2019, with a slight decrease each year from approximately 6.45 billion US dollars to around 6.44 billion US dollars. However, there was a significant increase in 2020, rising to approximately 7.91 billion US dollars. In 2021, the debt slightly decreased to about 7.69 billion US dollars, indicating a reduction after the peak the previous year.

Total Biogen Inc. Shareholders’ Equity

Shareholders' equity showed a consistent upward trend from 2017 to 2019, growing from approximately 12.61 billion US dollars to 13.34 billion US dollars. In 2020, there was a notable decline to about 10.70 billion US dollars. This followed by a modest recovery in 2021, with equity increasing to approximately 10.90 billion US dollars, yet still below the peak levels observed in 2019.

Invested Capital

Invested capital experienced steady growth from 2017 through 2019, rising from approximately 12.48 billion US dollars to 14.14 billion US dollars. In 2020, invested capital dropped to about 12.63 billion US dollars but rebounded in 2021 to 13.82 billion US dollars. This pattern suggests some disruptions or adjustments during 2020, followed by partial recovery the following year.

The financial performance from 2017 to 2021 is characterized by a significant period of expansion in economic value creation followed by a sharp contraction. While the company demonstrated strong growth in economic profit and capital efficiency through 2019, the subsequent two years show a marked decline, culminating in a near-total erosion of the economic spread by the end of 2021.

Economic Profit Trajectory

Economic profit exhibited a strong upward trend in the early part of the period, rising from 1,705,874 thousand US dollars in 2017 to a peak of 4,694,062 thousand US dollars in 2019. This growth was followed by a reversal, with profit declining to 3,255,688 thousand US dollars in 2020 and experiencing a severe drop to 307,383 thousand US dollars in 2021, representing a substantial decrease in the value generated above the cost of capital.

Invested Capital Dynamics

Invested capital remained relatively stable over the five-year period, fluctuating within a range of approximately 12.4 billion to 14.1 billion US dollars. Capital peaked in 2019 at 14,142,400 thousand US dollars before a slight contraction in 2020 and a subsequent increase to 13,824,500 thousand US dollars in 2021. The stability of the capital base indicates that the volatility in economic profit was driven by operational performance rather than drastic changes in the investment scale.

Economic Spread Ratio Analysis

The economic spread ratio mirrors the trajectory of economic profit, reflecting a peak in capital efficiency in 2019 at 33.19%. The ratio grew rapidly from 13.67% in 2017, signaling an increasing ability to generate returns well above the cost of capital. However, this trend inverted sharply after 2019, falling to 25.79% in 2020 and plummeting to 2.22% in 2021, indicating that the return on invested capital has converged closely with the cost of capital.

An analysis of economic value added metrics from 2017 to 2021 reveals a trajectory of initial growth followed by a significant contraction. The period is characterized by a peak in value creation in 2019, succeeded by a sharp decline that culminated in 2021.

Economic Profit Trends

Economic profit exhibited strong growth in the first three years of the period, increasing from 1,705,874 thousand US dollars in 2017 to a peak of 4,694,062 thousand US dollars in 2019. However, this trend reversed in 2020, with profit falling to 3,255,688 thousand US dollars, and collapsed further in 2021 to 307,383 thousand US dollars. This represents a substantial reduction in the absolute economic value generated, with the 2021 figure falling well below the 2017 baseline.

Revenue Performance

Revenue patterns largely mirrored the economic profit trajectory, growing steadily from 12,273,900 thousand US dollars in 2017 to a peak of 14,377,900 thousand US dollars in 2019. Following this peak, revenue decreased to 13,444,600 thousand US dollars in 2020 and contracted further to 10,981,700 thousand US dollars by the end of 2021. The simultaneous decline in both revenue and economic profit suggests a correlation between top-line contraction and the erosion of economic value.

Economic Profit Margin Analysis

The economic profit margin experienced a period of rapid expansion, rising from 13.90% in 2017 to a high of 32.65% in 2019, indicating a significant increase in the efficiency of value creation relative to revenue. This efficiency diminished in 2020 to 24.22% and fell precipitously to 2.80% in 2021. The severe compression of the margin in 2021 indicates that the company's returns barely exceeded its cost of capital by the end of the analyzed period.